Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP & CFO | May 30, 2025 | June 03, 2025 |
| INSULET CORPPODD · Entity 3516 | EVP & CFO | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 30, 2025 · Filed June 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,297 |
Ending reported balance
After 2025-05-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-05-30 · Grant · Acquired 7,152 · Balance 17,482 F1: Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029. Row 2 · 2025-05-31 · Tax withholding · Disposed 185 · Balance 17,297 |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029.
INSULET CORP
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,357 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 1,882 · Balance 17,357 F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2: Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
F2: Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 21:40 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 1,882 | $130.79 | $246,146.78 |
DisclosureSEC source: 0001145197-26-000186 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,357 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 · balance_after: Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:05 UTC | INSULET CORP PODD · Entity 3516 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,946 | $0.00 Strike: $245.25 | $0.00 |
DisclosureSEC source: 0001145197-26-000059 · form4.xml · derivative · entry 2 Pease Flavia · CIK 0001924996 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,946 Underlying: Common Stock · 9,946 shares Expires 2036-02-24 F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:05 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 3,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001145197-26-000059 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,159 F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in substantially equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:19 UTC | INSULET CORP PODD · Entity 3516 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,641 | $305.98 Strike: $305.98 | $502,113.18 |
DisclosureSEC source: 0001145197-25-000055 · form4.xml · derivative · entry 2 Pease Flavia · CIK 0001924996 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,641 Underlying: Common Stock · 1,641 shares Expires 2035-10-01 F2 · derivative.exercise_date: The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:19 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 11,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001145197-25-000055 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,337 F1 · shares: Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 21:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 185 | $135.63 | $25,091.55 |
DisclosureSEC source: 0001127602-25-016569 · form4.xml · nonDerivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,297 Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 7,152 | $135.63 | $970,025.76 |
DisclosureSEC source: 0001127602-25-016569 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,482 F1 · shares: Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:10 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 141 | $136.73 | $19,278.93 |
DisclosureSEC source: 0001127602-25-015906 · form4.xml · nonDerivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,330 Read SEC document |
| May 26, 2025 Filed May 29, 2025 21:10 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 190 | $136.73 | $25,978.70 |
DisclosureSEC source: 0001127602-25-015906 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,471 Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:09 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015656 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,629 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2026. The Reporting Person has elected to defer settlement of these RSUs pursuant to the Insulet Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the termination of the Reporting Person's service as a Director. Read SEC document |
| May 02, 2025 Filed May 5, 2025 21:44 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 889 | $116.89 | $103,915.21 |
DisclosureSEC source: 0001127602-25-013391 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,661 Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 914 | $165.57 | $151,330.98 |
DisclosureSEC source: 0001127602-25-002799 · form4.xml · nonDerivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,550 Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 22:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-002799 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,464 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,906 | $208.44 Strike: $208.44 | $1,022,606.64 |
DisclosureSEC source: 0001127602-24-017663 · form4.xml · derivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,906 Underlying: Common Stock · 4,906 shares Expires 2034-05-31 F2 · shares: Stock options vest as follows: 1,226 on May 31, 2025, 1,227 on May 31, 2026, 1,226 on May 31, 2027, and 1,227 on May 31, 2028. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017663 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,760 F1 · shares: Unvested restricted stock units vest as follows: 539 on May 31, 2025, 540 on May 31, 2026, 540 on May 31, 2027, and 540 on May 31, 2028. Read SEC document |
| May 27, 2024 Filed May 29, 2024 21:38 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 144 | $217.21 | $31,278.24 |
DisclosureSEC source: 0001127602-24-016811 · form4.xml · nonDerivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,651 Read SEC document |
| May 27, 2024 Filed May 30, 2024 23:56 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 194 | $217.21 | $42,138.74 |
DisclosureSEC source: 0001127602-24-017055 · form4a.xml · nonDerivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,601 Read SEC document |
| May 26, 2024 Filed May 29, 2024 21:38 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 212 | $217.21 | $46,048.52 |
DisclosureSEC source: 0001127602-24-016811 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,795 Read SEC document |
| May 26, 2024 Filed May 30, 2024 23:56 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 212 | $217.21 | $46,048.52 |
DisclosureSEC source: 0001127602-24-017055 · form4a.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,795 Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:12 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016462 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,851 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2025. The Reporting Person has elected to defer settlement of these RSUs pursuant to the Insulet Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the termination of the Reporting Person's service as a Director. Read SEC document |
| May 02, 2024 Filed May 3, 2024 21:03 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 893 | $232.69 | $207,792.17 |
DisclosureSEC source: 0001127602-24-014153 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,007 Read SEC document |
| January 18, 2024 Filed Jan 22, 2024 21:10 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-001807 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,471 F1 · shares: Initial equity award in the form of restricted stock units ("RSUs"). RSUs vest 50% on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant. The RSUs are settled in shares of common stock on a one-for-one basis. Read SEC document |
| May 27, 2023 Filed May 31, 2023 18:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 137 | $194.12 | $26,594.44 |
DisclosureSEC source: 0001127602-23-017170 · form4.xml · nonDerivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,900 Read SEC document |
| May 26, 2023 Filed May 31, 2023 18:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 5,314 | $194.12 Strike: $194.12 | $1,031,553.68 |
DisclosureSEC source: 0001127602-23-017170 · form4.xml · derivative · entry 3 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,314 Underlying: Common Stock · 5,314 shares Expires 2033-05-26 F2 · shares: Stock Options vest as follows: 1,328 on May 26, 2024, 1,329 on May 26, 2025, 1,328 on May 26, 2026 and 1,329 on May 26, 2027. Read SEC document |
| May 26, 2023 Filed May 31, 2023 18:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017170 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,037 F1 · shares: Restricted Stock Units vest as follows: 553 on May 26, 2024, 554 on May 26, 2025, 554 on May 26, 2026 and 554 on May 26, 2027. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,423 | $244.41 Strike: $244.41 | $1,081,025.43 |
DisclosureSEC source: 0001127602-22-016211 · form4.xml · derivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,423 Underlying: Common Stock · 4,423 shares Expires 2032-05-27 F2 · shares: Stock Options vest as follows: 1,105 on May 27, 2023, 1,106 on May 27, 2024, 1,106 on May 27, 2025 and 1,106 on May 27, 2026. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016211 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,822 F1 · shares: Unvested restricted stock units vest as follows: 409 on May 27, 2023, 409 on May 27, 2024, 409 on May 27, 2025 and 410 on May 27, 2026. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:38 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,649 | $245.88 Strike: $245.88 | $1,143,096.12 |
DisclosureSEC source: 0001127602-22-013202 · form4.xml · derivative · entry 2 Pease Flavia · CIK 0001924996 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,649 Underlying: Common Stock · 4,649 shares Expires 2032-05-02 F2 · shares: Stock Options vest as follows: 2,324 on May 02, 2024, and 2,325 on May 02, 2025. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:38 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 5,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013202 · form4.xml · nonDerivative · entry 1 Pease Flavia · CIK 0001924996 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,185 F1 · shares: Unvested restricted stock units vest as follows: 2,592 on May 02, 2024, and 2,593 on May 02, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.